All In Biotech

Drug Trial Radar · NCT05528172

A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery

A Double-Masked, Randomized, Placebo-Controlled, Parallel-Group, 12-Week Treatment and 14-week Extension, Phase 3 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery

Last checked: Nov 19, 2026Latest source record: Sep 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 330 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

330

Actual

Start

Aug 4, 2022

Primary completion

Jun 22, 2023

Study completion Jun 22, 2023

Sponsor

Lead sponsor
Kowa Research Institute, Inc.Industry
Sponsor type
Industry
First posted
Sep 6, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the safety and efficacy of K-321 in subjects after cataract surgery

Conditions

  • Corneal Edema After Cataract Surgery

Interventions

  • RipasudilDrug

    K-321 ophthalmic solution

  • PlaceboDrug

    Placebo ophthalmic solution

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Central Corneal Endothelial Cell Density (ECD) at Week 12Time frame: Baseline to Week 12

Locations

45 sites in 2 countries. Site status is shown where the registry gives one.

  • Cornea and Cataract Consultants of Arizona

    Phoenix, Arizona

  • Schwartz Laser Eye Center

    Scottsdale, Arizona

  • Inland Eye Specialists

    Hemet, California

  • United Medical Research Institute

    Inglewood, California

  • Alvarado Eye Associates

    La Mesa, California

  • SoCal Eye Physicians and Associates

    Long Beach, California

  • Visionary Research Institute

    Newport Beach, California

  • Pendleton Eye Center

    Oceanside, California

  • North Bay Eye Associates

    Petaluma, California

  • Martel Eye Medical Group

    Rancho Cordova, California

  • Premiere Practice Management, LLC

    Torrance, California

  • Wolstan and Goldberg Eye Associates

    Torrance, California

  • Icon Eye Care

    Grand Junction, Colorado

  • Eye Associates of Fort Myers

    Fort Myers, Florida

  • Levenson Eye Associates

    Jacksonville, Florida

  • International Research Center

    Tampa, Florida

  • Clayton Eye Clinical Research, LLC

    Morrow, Georgia

  • Durrie Vision

    Overland Park, Kansas

  • Eye Care Institute/Butchertown Clinical Trials

    Louisville, Kentucky

  • Maine Eye Center

    Portland, Maine

  • Fraser Eye Care Center

    Fraser, Michigan

  • Silverstein Eye Centers

    Kansas City, Missouri

  • Tekwani Vision Center

    St Louis, Missouri

  • Ophthalmology Associates

    St Louis, Missouri

  • Ophthalmology Consultantants, Ltd.

    St Louis, Missouri

  • Comprehensive Eye Care, Ltd.

    Washington, Missouri

  • Vance Thompson Vision-MT

    Bozeman, Montana

  • Vance Thompson Vision- NE

    Omaha, Nebraska

  • Wellish Vision Institute

    Las Vegas, Nevada

  • Center for Sight

    Las Vegas, Nevada

  • NYU Grossman School of Medicine

    New York, New York

  • Seeta Eye Center

    Poughkeepsie, New York

  • Vance Thompson Vision ND

    West Fargo, North Dakota

  • Cincinnati Eye Institute

    Cincinnati, Ohio

  • Cincinnati Eye Institute

    Mason, Ohio

  • Eye Care Specialists

    Kingston, Pennsylvania

  • Vance Thompson Vision

    Sioux Falls, South Dakota

  • Keystone Research

    Austin, Texas

  • Hill Country Eye Center

    Cedar Park, Texas

  • Louis M. Alpern, M.D., M.P.H.,P.A.

    El Paso, Texas

Showing 40 of 45 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.